David Rimm

97PUBLICATIONS
352CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersGene and molecular therapyTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (97)

|Apr 20, 2026
Quantification of Antibody-Drug Conjugate Targets in Head and Neck Squamous Cell Carcinoma.

|Feb 19, 2026
Quantitative Assays for TROP2 Measurement in Breast Cancer and Comparison to H-Score.

Mengni He, Nay N N Chan, Matthew Liu

|Feb 03, 2026
Metabolic characterization of tumor-immune interactions by multiplexed immunofluorescence reveals spatial mechanisms of immunotherapy response in non-small cell lung carcinoma (NSCLC).

James Monkman, Aaron Kilgallon, Clara Lawler

|Dec 21, 2025
Society for Immunotherapy of Cancer: Standards for Reporting of Multiplex Immunohistochemistry/Immunofluorescence Assays (STORMI).

Sam Sater, Carlo B Bifulco, Jaime Rodriguez-Canales

|Nov 14, 2025
Mixed Molecular Subtypes Coexist in Estrogen Receptor Heterogeneous Primary Breast Cancers.

Julia Foldi, Kaitlyn Xiong, Matthew Liu

|Oct 10, 2025
Spatial signatures for predicting immunotherapy outcomes using multi-omics in non-small cell lung cancer.

Thazin N Aung, James Monkman, Jonathan Warrell

Pageof 17

Frequent Collaborators

15 joint publications

Thazin Nwe Aung

11 joint publications

Lajos Pusztai

11 joint publications

Niki Gavrielatou

9 joint publications

Ioannis Vathiotis